Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Pollution's reach extends to cancer outcomes. An Italian study found that patients with localised adrenocortical carcinoma (ACC) living in government-designated contaminated zones had dramatically shorter recurrence-free and overall survival compared to those in cleaner areas. Urbanisation level, however, made no difference in outcomes.
Where you live may shape how well you survive cancer. A retrospective Italian study of 336 adrenocortical carcinoma (ACC) patients found that those with localised disease residing in National Priority Contaminated Sites (NPCS) — areas officially flagged for high-risk industrial pollution — fared significantly worse than patients in non-contaminated areas. Tumours in NPCS residents were also more likely to be symptomatic at diagnosis, suggesting more aggressive disease behaviour.
Researchers noted that environmental pollutants may directly fuel tumour aggressiveness, compounding already poor prognoses in a rare and difficult-to-treat cancer. Notably, urbanisation level (city vs. rural) had no bearing on outcomes, pointing specifically to industrial contamination — not population density — as the key factor.
By the Numbers:
Why it matters: This study adds rare-cancer evidence to the growing body of research linking environmental pollution to worse health outcomes, raising important questions about industrial site regulation and cancer surveillance in affected communities.
